Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
FRAMINGHAM, Mass. and SYDNEY, Aug. 8, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $50.8 million for the second quarter ended June 30, 2013, a 75% increase compared to $29.1 million in revenue for the same period of 2012.
Hey, check out all the research scientist jobs. Post your resume today!
